December 20, 2024

Bio-interventional Cyclodialysis with Allograft Scleral Reinforcement for OAG

The combined procedure decreased IOP and improved BCVA.

Conexiant

December 20, 2024

Empagliflozin Reduces Risk of Diabetic Retinopathy Progression

Investigators found a 22% reduced risk of progression in patients with preexisting NPDR.

Conexiant

December 20, 2024

Workplace Discrimination in Ophthalmology

“Your husband also works, so you’re the second income.’”

Conexiant

December 18, 2024

Can Jardiance Slow Diabetic Eye Disease?

A recent report in JAMA Ophthalmology reveals that Jardiance, an oral diabetes drug, may help prevent worsening of diabetic eye disease in patients with type 2 diabetes, offering valuable insights for clinical management.

Reuters

December 17, 2024

Objective Perimetry More Sensitive than Standard Automated Perimetry

Study finds multifocal pupillographic objective perimetry is a faster, more reliable approach to glaucoma diagnostics compared to standard automated perimetry.

Conexiant

December 13, 2024

Obstructive Sleep Apnea Affects nAMD

The potential overnight reduction of the critical oxygen supply could present a retinal health risk.

Conexiant

December 13, 2024

Large Study Reveals Melanoma's Hidden Risks

Analysis of over 280,000 melanoma patients reveals these survivors face significantly elevated risks of developing 12 different types of second primary cancers, with the risk being particularly pronounced in younger patients and those with thicker tumors.

Conexiant

December 13, 2024

Faricimab Shows Better Anatomic Outcomes Compared to Aflibercept for nAMD

New data from TENAYA and LUCERNE supports “the vascular stabilizing effects of Ang-2 inhibition beyond anti-VEGF-A alone.”

Conexiant

December 13, 2024

Detailed Connections between Geographic Atrophy Lesions and Vision Loss

Study explores discord between BCVA and GA lesion size.

Conexiant